Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Hydrophobic interactions drug absorption

Azone (laurocapram) is used extensively as a transdermal permeation enhancer, and has also found use in buccal drug delivery. It is a lipophilic surfactant in nature (Figure 10.4). Permeation of salicylic acid was enhanced by the pre-application of an Azone emulsion in vivo in a keratinized hamster cheek pouch model [35]. Octreotide and some hydrophobic compounds absorption have also been improved by the use of Azone [36], Azone was shown to interact with the lipid domains and alter the molecular moment on the surface of the bilayers [37], In skin it has been proposed that Azone was able to form ion pairs with anionic drugs to promote their permeation [38],... [Pg.208]

Intemasal delivery of peptide and protein drugs is severely restricted by pre-systemic elimination due to enz5miatic degradation or mucociliary clearance and by the limited extent of mucosal membrane permeability. a-CyD has been shown to remove some fatty acids from nasal mucosa and to enhance the nasal absorption of leuprolide acetate in rats and dogs. The utility of chemically modified CyDs as absorption enhancers for peptide drugs in rats has been demonstrated. For example, DM-P-CyD was shown to be a potent enhancer of insulin absorption in rats, and a minimal effective concentration of DM-(3-CyD for absorption enhancement exerted only a mild effect on the in vitro ciliary movement.The scope of interaction of insulin with CyDs is limited, because CyDs can only partially include the hydrophobic amino acid residues in peptides with small stability constants. Under in vivo conditions, these complexes will readily dissociate into separate components, and hence the displacement by membrane lipids may further destabilize the complexes. The direct interaction of peptides with CyDs is therefore of minor importance in the enhancement of nasal absorption. Of the hydrophilic CyDs tested, DM- 3-CyD had the most prominent inhibitory effect on the enzymatic degradation of both BLA and insulin in rat nasal tissue homogenates. Because of the limited interaction between peptides and CyDs,... [Pg.826]

In the context of drug-like substances, hydrophobicity is related to absorption, bioavailability, hydrophobic drug-receptor interactions, metabolism and toxicity. Closely related to log P is the octanol-water distribution coefficient (logDpn), accounting for partition of pH-dependent mixture of ionizable species. Ionization of any compound makes it more water soluble and then less lipophilic. The log D can be calculated from log Pand acid dissociation constant pJC, by the following expression [Cronin, Aptula et al, 2002b Livingstone, 2003] ... [Pg.590]


See other pages where Hydrophobic interactions drug absorption is mentioned: [Pg.199]    [Pg.24]    [Pg.173]    [Pg.33]    [Pg.516]    [Pg.377]    [Pg.309]    [Pg.307]    [Pg.257]    [Pg.183]    [Pg.2595]    [Pg.2707]    [Pg.1940]    [Pg.249]    [Pg.210]    [Pg.261]    [Pg.222]    [Pg.84]    [Pg.388]    [Pg.43]    [Pg.119]    [Pg.234]    [Pg.144]    [Pg.353]    [Pg.315]    [Pg.417]    [Pg.315]    [Pg.114]    [Pg.76]    [Pg.157]    [Pg.329]    [Pg.461]    [Pg.655]    [Pg.36]    [Pg.919]    [Pg.94]    [Pg.824]    [Pg.59]    [Pg.113]    [Pg.132]    [Pg.93]    [Pg.658]    [Pg.661]    [Pg.1133]    [Pg.52]    [Pg.383]   
See also in sourсe #XX -- [ Pg.95 ]




SEARCH



Drug absorption

Drug absorption interactions

Hydrophobic drugs

Hydrophobic interactions

Hydrophobic/hydrophobicity interactions

Hydrophobicity absorption

Hydrophobized interaction

© 2024 chempedia.info